Keith Graham

USPTO Granted Patents = 13 (Patent Applications = 31)

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 45)

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

9 out of 378

Bayer Pharma Aktiengesellschaft

Bayer Aktiengesellschaft

patents

4. 1 out of 1,206

Dana-farber-cancer Institute Inc.

patents

5. 1 out of 443

The Broad Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2022-05-24),

2. 10487092 - Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors (2019-11-26),

3. 10428063 - 4H-pyrrolo[3,2-C]pyridin-4-one derivatives (2019-10-01),

4. 10428044 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones (2019-10-01),

5. 10308629 - 1H-pyrrol-3-amines (2019-06-04),

6. 10227299 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones (2019-03-12),

7. 9675612 - Substituted thiazolopyrimidines (2017-06-13),

8. 9540392 - Thienopyrimidines (2017-01-10),

9. 9375497 - [F-18]-labeled L-glutamic acid, [F-18]-labeled L-glutamine, derivatives thereof and use thereof and processes for their preparation (2016-06-28),

10. 9308282 - [F-18]-labelled L-glutamic acid and L-glutamine derivatives (I), their use and processes for their preparation (2016-04-12),

11. 9238631 - Radiolabeled amino acids for diagnostic imaging (2016-01-19),

12. 8968701 - Usage of low to medium-pressure liquid chromatography for the purification of radiotracers (2015-03-03),

13. 8557776 - [object Object] (2013-10-15),

Title: Inventor Keith Graham: Pioneering Pharmaceutical Innovations in Berlin

Introduction

Keith Graham, a renowned inventor based in Berlin, Germany, holds an impressive portfolio of 13 patents. His significant contributions to the field of pharmaceuticals have garnered attention and respect in the scientific community.

Latest Patents

Graham's latest innovations include novel derivatives of 4H-pyrrolo[3,2-c]pyridin-4-one. He has developed processes for creating these compounds and outlined their potential use as pharmaceuticals. Another noteworthy invention is centered around pyrazolopyridinamines which serve as inhibitors for MKNK1 and MKNK2. This invention details substituted pyrazolopyridinamine compounds that can be utilized in treating various diseases, particularly those relating to hyperproliferative disorders, inflammation, and associated pain.

Career Highlights

Throughout his career, Keith Graham has been associated with esteemed companies such as Bayer Pharma Aktiengesellschaft and Piramal Imaging. His innovative work in these organizations has led to a deeper understanding of pharmaceutical compounds and their applications in medical treatment.

Collaborations

Graham has collaborated with notable colleagues in the industry, including Ulrich Klar and Philip Lienau. These partnerships have been essential in advancing his research and contributing to the success of his inventions.

Conclusion

Keith Graham continues to impact the pharmaceutical industry through his groundbreaking inventions and active collaboration with fellow scientists. His dedication to innovation positions him as a prominent figure in the realm of pharmaceutical research, providing new solutions to complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.